A Single Dose Study of MK-8266 (MK-8266-001)
Clinical trial NCT01025791 · COMPLETED
Trial details
- NCT number
- NCT01025791
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-18
- Primary completion
- 2010-05-14
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.